A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold ResponseDuško Lainšček, Roman Jerala, Jana Aupič et al.|Vaccines|2021Cited by 36
Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumorsSara Orehek, Iva Hafner‐Bratkovič, Taja Železnik Ramuta et al.|Nature Communications|2024Cited by 33
Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike proteinDuško Lainšček, Roman Jerala, Tina Fink et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 10
Engineering chimeric PCSK9 for a vaccine against atherosclerosisŠpela Malenšek, Roman Jerala, Duško Lainšček et al.|Molecular Therapy — Methods & Clinical Development|2025Cited by 3
Hydroxychloroquine decouples reactogenicity from efficacy in mRNA and viral-vector gene deliveryDuško Lainšček, Roman Jerala, Špela Malenšek et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0